Annual Drug Patent Expirations for XELSTRYM
Xelstrym is a drug marketed by Noven Pharms Inc and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
Drug patent litigation for XELSTRYM.
This drug has twenty-seven patent family members in eleven countries.
The generic ingredient in XELSTRYM is dextroamphetamine. One supplier is listed for this compound. Additional details are available on the dextroamphetamine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com